RxDoctor Payments Data

Joshua Kelsey, PA

Physician Assistant · Bemidji, MNNPI 1528471703

Payments from drug & device makers

$3,495in general payments, 2019–2025

Across 93 payments — averaging $37.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bard Peripheral Vascular, Inc.$864
  • W. L. Gore & Associates, Inc.$792
  • Abbott$674
  • Medtronic$607
  • Boston Scientific$128
  • BD$106
  • plus $325 from 8 others

What the payments were for

  • Food & beverage$3,495100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,495 in reported general payments places this provider in the 95th percentile of 3,121 physician assistant providers in Minnesota.

See all physician assistant providers in Minnesota

Medicare billing

Part B allowed, 2024
$37,862
Medicare patients
363
Services billed
493

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban383$387,175
XareltoRivaroxaban93$112,073
EntrestoSacubitril/Valsartan54$67,010
JardianceEmpagliflozin49$52,917
FarxigaDapagliflozin Propanediol43$41,106
BrilintaTicagrelor22$13,418
Metoprolol Succinate512$6,918
Breo ElliptaFluticasone/Vilanterol12$5,164
Atorvastatin Calcium375$4,939
ClopidogrelClopidogrel Bisulfate347$4,350
Losartan Potassium262$3,173
Isosorbide Mononitrate ErIsosorbide Mononitrate177$2,803
Rosuvastatin Calcium199$2,654
Flecainide Acetate56$2,496
Diltiazem 24hr Er (Cd)Diltiazem Hcl88$2,274

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
NovartisEntresto$30$67,01054 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,121 physician assistant providers in Minnesota.

Other physician assistant in Bemidji

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →